Market Tracker

07/26 2:48pm ET

SPDR® S&P Biotech ETF (XBI)

80.70
BATS BZX Real-Time Price
As of 2:47pm ET
 +0.09 / +0.11%
Today’s Change
53.15
Today|||52-Week Range
82.38
+36.34%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+0.23% 3 years+18.80%
3 months+14.19% 5 years+22.51%
1 year+35.80% Since inception+15.22%
Data through 07/26/2017

Quote Details

Previous close$80.61
Open day’s range80.58 – 81.36
Net asset value (NAV)80.54 (07/25/2017)
Daily volume231,803
Average volume (3 months)4,267,098
Data as of 2:47pm ET, 07/26/2017

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+22.51%+17.39%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.791.14
Net assets$3.5B$3.0B
Average market cap$4.6B$30.8B
Average P/E--24.5
Dividend / Share--0.30%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CLVS Clovis Oncology Inc2.96%
EXEL Exelixis Inc2.44%
KITE Kite Pharma Inc2.26%
ALXN Alexion Pharmaceuticals Inc2.21%
CELG Celgene2.10%
ALNY Alnylam Pharmaceuticals Inc2.09%
GILD Gilead Sciences2.09%
SRPT Sarepta Therapeutics Inc2.05%
EXAS Exact Sciences Corp2.02%
INCY Incyte Corp2.02%